To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Researchers have resurrected an ancient gene humans lost tens of millions of years ago — and it may offer a powerful new way to fight gout and related metabolic diseases. Credit: Shutterstock Gout is ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. It might not seem so obvious when walking past rows of vacuum-sealed ...

Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. Citing safety concerns, the Downtown Bozeman Partnership Management Committee withdrew Ghassane ...